Date:
October 20, 2026
Content:
The Food and Drug Administration has released a regulatory update concerning LCC Ltd., a manufacturing firm based in Korea. This notification follows recent agency oversight activities and facility inspections.
The FDA’s communication regarding LCC Ltd. (FEI: 3007255059) stems from a formal review of the company’s manufacturing standards and compliance protocols. These updates are part of the agency’s ongoing commitment to ensuring that international facilities adhering to U.S. safety and quality regulations for products distributed in the domestic market.
Typically, such updates involve findings related to Current Good Manufacturing Practice (CGMP) requirements. The agency uses these public disclosures to inform stakeholders of manufacturing deficiencies that must be addressed to ensure consumer safety and product integrity.
The company is expected to implement corrective actions to resolve any outstanding issues identified by the agency. Interested parties can monitor the official FDA compliance portal for further developments regarding this facility’s regulatory status.
Source: FDA
Link:
http://www.fda.gov/about-fda/lcc-ltd
Keywords:
FDA, LCC Ltd, Korea, Manufacturing Standards, Regulatory Update, CGMP Compliance